Another year, another list of the Top U.S. Cities for Global Trade. If there’s one thing that strikes us about this list over the past couple of years is that the reach of the global economy has not just stretched to other shores but into virtually every city in the United States, no matter the size.


MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, today announced that AblaCare, CroiValve, FineHeart, Sana Health, and Spect have been selected as finalists to compete for the title of MedTech Innovator of 2018, out of over 700 applicants. The Grand Prize winner of $350,000 will be determined by the vote of the audience at the largest gathering of medtech industry leaders in North America on Sept. 25 in Philadelphia, PA at The MedTech Conference, powered by AdvaMed.


Expanding its portfolio of innovative health solutions, the Inova Personalized Health Accelerator (IPHA) has invested in a new therapy company that is developing a solution to address a major unmet need in patients with olfactory impairment. Sense of smell can often be taken for granted, until it is lost. This occurs most commonly by sino-nasal disease and upper respiratory infection, and in many cases, by head trauma. Cyrano Therapeutics understands the profound impact these senses can have on quality of life and is developing the first safe and effective nasal spray to restore and maintain the sense of smell and its connection with the ability to detect flavor in food (often perceived as taste). According to the peer-reviewed journal BMC Ear, Nose and Throat Disorders, 14 million patients in the United States have olfactory impairment or loss of smell, yet few treatments are available. 


On September 23rd, Montgomery County residents will gather at the Music Center at Strathmore in North Bethesda for the Leggett Legacy Forward event celebrating County Executive Ike Leggett and his wife Catherine’s years of outstanding service and their commitment to higher education. The event is a culmination of their effort to establish a legacy gift that will serve the county in perpetuity -- the Ike and Catherine Leggett Scholarship. The scholarship will benefit the county’s historically underrepresented students in higher education through the Achieving Collegiate Excellence and Success (ACES) program.


Creatv MicroTech, Inc. (Creatv) has received a $625,000 award from the Department of Defense Congressionally Directed Medical Research Programs (CDMRP) to investigate their discovery of giant circulating cells found in peripheral blood for non-invasive detection of lung cancer by differentiating malignant from benign pulmonary nodules detected by low dose CT (LDCT). In the three-year study, Creatv will examine blood samples from 1,250 subjects at high risk for lung cancer based on their smoking history and occupational exposure to carcinogens. The research will be carried out in collaboration with Fox Chase Cancer Center (FCCC) and the Philadelphia VA Hospital.


The Sheik Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System is pleased to announce the 11 finalists who have been selected to pitch their pediatric medical device innovation at our 6th annual Pediatric Device Innovation Symposium on Sunday, Sept. 23rd in Philadelphia, PA.

New this year, the competition focused on pediatric cardiovascular devices as they are critically needed. From a field of 45 submissions, the finalists are:


Event date: November 07, 2018 SAVE THE DATE!

Please mark your calendar to join us at the Fall 2018 Inova Discovery Series: The Impact of Changing Consumer Expectations on Healthcare Delivery.

Consumer expectations related to healthcare delivery continue to rapidly evolve, forcing health systems and health technology innovators to continually rethink how consumers view the traditional patient-provider-payor relationship. 


It's no secret that choosing the right college can have a big impact on where you end up later in life.

If you're hoping to launch a startup, chances are you'll need some funding down the road -- and, according to the data, the university you attend can be one factor that impacts the amount of funding you'll receive after graduating.


Technologies such as cloud, bigdata, nosql databases, mobile apps, wearable sensors, and healthcare data interoperability are buzz words to many, but they are technologies that are propelling the healthcare-IT field forward into new frontiers.  The possibilities these technologies bring can aide in patient engagement, data aggregation, integration and analytics for precision medicine. This is the cutting-edge space that Jeeva Informatics, a local company, operates in.  It’s also a very attractive field for students who are eager to get work experience in the emerging technologies of the future.


Cybersecurity influencers believe that a new wave of system-embedded devices present a formidable challenge to their field. The Internet of Things (IoT) will introduce a vast amount of small computers, with inadequate security designs, that use high-speed internet, and that combination has all the ingredients for a cyberspace disaster.

Bob Stratton, a security entrepreneur and consultant, states that not every device has to have the high-level security of desktop computers, but manufactures of small computers should include a built-in level of resistance and system integrity.


ExeGi Pharma is pleased to announce two new clinical partnerships with the College of Veterinary Medicine at the University of Georgia and the University of Tennessee to study the Visbiome Vet probiotic in domestic dogs. Both studies will evaluate the probiotic's effectiveness in managing canine gastrointestinal disorders. Visbiome Vet is an 8-strain probiotic compound with an extremely high concentration of beneficial bacteria (112.5 billion bacteria per dose). The formulation in Visbiome Vet is one of the most extensively studied probiotic products for pets, as it has been the subject of four controlled clinical trials.


The U.S. Food and Drug Administration announced today that it has awarded five grants totaling up to $6 million per year over the next five years to Pediatric Device Consortia (PDC) across the country that will provide advice and support services to innovators of children's medical devices. The program aims to enhance the development, production and distribution of pediatric medical devices and has awarded $37 million to various consortia since 2009.


Enjoy an evening with food, fun and lively conversation at Biotech and Beer. Meet old friends and new colleagues in the life science community. Complimentary admission for any bioscience company employees, and university students and researchers with advanced registration. All others may purchase tickets.

When: Thursday, Septmember 27, 2018 4:00-7:00 PM

Where: Farm Brew Live 9901 Discovery Blvd. Manassas, Virginia  20109 United States


For small businesses currently participating in the federal government’s Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) programs, understanding intellectual property (IP)—including patents, trade secrets, trademarks, and copyrights—is necessary to protect your ideas, products, and product names in today’s knowledge economy. This series of seven 90-minute webinars, organized by the USPTO and the U.S. Small Business Administration, has been designed to specifically address the most common IP issues facing small businesses funded by the SBIR and STTR programs. They not only cover all aspects of IP protection, but will also help you understand your IP data rights under the SBIR/STTR grant or contract.

Space is limited to 200 people per webinar, so early registration is advised. Please note these webinars are open only to small businesses currently engaged in either Phase 1 or Phase 2 of the SBIR/STTR programs (link is external).


Part 1 considered Dr. Kelvin Stott’s characterization of the innovation crisis in the pharmaceutical industry (here, here) and found his technology-based solution wanting. Improved productivity will require a new business model, one with transformative potential.


What you get

Participants selected for cohort three will receive: *

  • A two-year fellowship – Includes a personal living stipend of up to $90,000/year depending on education and experience, along with health insurance and travel allowance
  • Lab access and research funding – In addition to unparalleled access to facilities, equipment, and expertise at Oak Ridge National Laboratory, fellows receive $200,000 of R&D funding to support collaboration opportunities with researchers across the lab.
  • Business mentors, entrepreneurial training, and networking – Participants receive access to experienced business mentors, entrepreneurial training programs, and exclusive networking opportunities. Innovators are also exposed to a wide range of leaders from academia, industry, government, and finance that can serve as advisors and partners.

*All support is subject to performance and availability of funds.

Eligibility criteria

For acceptance into the program, applicants:

  • Must have PhD or equivalent experience
  • Must be focused on energy or manufacturing innovation
  • Must leverage ORNL R&D capabilities and have an impact on the Department of Energy (DOE) or Tennessee Valley Authority (TVA) mission
  • Must be willing to relocate to the Knoxville-Oak Ridge area
  • Must be a US citizen or lawful permanent resident at time of application

To learn more or to apply, please visit: https://innovationcrossroads.ornl.gov/.

Matt holds a Ph.D. in Virology from Ian Mohr’s lab at NYU Langone Medical Center.  He is also an inventor on all BeneVir patents protecting T-StealthTM, the first oncolytic virus to resist both innate and adaptive immunity. Prior to BeneVir, Matt spent 8 years at Sequella, Inc., a clinical stage anti-infectives company. At Sequella, he patented and developed a molecular diagnostic and licensed it to a major clinical diagnostics company. In addition, he designed and executed clinical trials and was involved in the development of Sequella’s antibiotic pipeline from pre-clinical to clinical.

Listen now on iTunes Google Play , and TuneIn


A critical stage for most first-time entrepreneurs is getting their idea developed into at least a prototype to validate their technology. This process costs money, which professional investors are not willing to contribute, since their interest is in scaling a proven product and business model into a growth business. Investors want potential for a large and timely return, with reduced risk.